{
    "organizations": [],
    "uuid": "e958957c2e21c63d06ec007a339e562ae628d696",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bbi-life-sciences-says-fy-profit-a/brief-bbi-life-sciences-says-fy-profit-attributable-rmb64-45-mln-idUSL8N1R8545",
    "ord_in_thread": 0,
    "title": "BRIEF-BBI Life Sciences Says FY Profit Attributable RMB64.45 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Bbi Life Sciences Corp:\n* PROPOSED FINAL DIVIDEND OF HK$0.014 PER ORDINARY SHARE * ‍FY REVENUE RMB462.40 MILLION, UP 31.4 PERCENT​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-26T23:26:00.000+03:00",
    "crawled": "2018-03-27T12:05:06.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "bbi",
        "life",
        "science",
        "corp",
        "proposed",
        "final",
        "dividend",
        "hk",
        "per",
        "ordinary",
        "share",
        "revenue",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}